Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

Rebranded Astaxin® now available in pharmacies

New-look astaxanthin-containing supplement launched in retail outlets in Sweden and Norway

The proven formula of Astaxin® – now with a new minimalist Nordic product design – combines microalgae-based astaxanthin with vitamins C and E. It is delivered in gelatin capsules in two different product sizes (60 and 120 capsules). With a recommended intake of one to two capsules daily, the supplement provides cell protection and supports an active and healthy lifestyle. Vitamin C and E protect cells against oxidative stress, which is validated by the health claim on the package. Additionally, vitamin C contributes to the normal functioning of the immune system and reduces fatigue and exhaustion. Each capsule also contains 4 mg of astaxanthin for additional health support.

AstaReal launched Astaxin® Original nearly 30 years ago as the first human dietary supplement containing a natural source of astaxanthin. With the rebranding, the Swedish astaxanthin pioneer has given a luxurious new feel to its well-established product. Nutraceutical companies got a first glance of Astaxin® at AstaReal’s booth at Fi Europe in Frankfurt at the end of 2023. Furthermore, the company plans to launch a vegan version of Astaxin® for the European market in the near future, following its launch in China.

Peter Ahlm, Head of Marketing & Sales at AstaReal, explains: “Astaxin® plays a key role in our mission to support the health of humans and wellbeing of the planet. Alongside our finished formulations for the retail market, we offer various bulk products of astaxanthin, all derived from sustainably cultivated microalgae Haematococcus pluvialis. AstaReal® astaxanthin is one of nature’s most powerful antioxidants with scientifically proven health benefits. The ingredient is highly future-proof, as it matches consumer demand for natural sustainable, and plant-based ingredients.”

About AstaReal AB
AstaReal AB is part of the AstaReal Group, which is a wholly owned subsidiary of the Japanese pharmaceutical company Fuji Chemical Industries Co. Ltd. The Group uses AstaReal® as the global brand name for its natural algal astaxanthin products. As a worldwide pioneer and expert in natural astaxanthin production, R&D and clinical science, the company offers a variety of specialized astaxanthin formats to help meet customer requirements when developing dietary supplements, sports nutrition products, cosmetics and animal feed. AstaReal AB is ISO 9001, HACCP, FSSC 22000, Informed Ingredient, Kosher, and Halal certified, and carries the Vegan Trademark for its bulk products. The company’s roots trace back to the prestigious Uppsala University, Sweden. Successfully proven benefits of natural astaxanthin for human health encouraged the scientists there to establish AstaReal’s first production facility in Gustavsberg, Sweden, in the early 1990s. In 1995, AstaReal AB launched Astaxin® – the first human nutritional supplement containing a natural source of astaxanthin. Today, AstaReal produces natural astaxanthin at facilities in Sweden and the USA. AstaReal AB offers private labelling, and is open to co-branding and joint product development.


For further information, please visit: http://www.astareal.se

Share the Post:

Related Posts

Symrise celebrates 150 shades of innovation with the milestone sun protection

As part of its “150 shades of innovation” campaign to mark the 150th anniversary of
the first patent of founding father Wilhelm Haarmann, Symrise is commemorating its
milestones. Symrise will put the second highlight on the pioneering work, processes,
and ingredients from their Sun Protection business. The Holzminden-based company
has been shaping this industry for over 70 years by leading research and delivering
game-changing product innovations in the skin and sun care space.

Read More

Fragrance Allergens and Their INCI Names in the Cosmetics

The updated naming conventions for essential oils and extracts of popular plant species to minimize discrepancies and prevent errors between the names of extracts derived from different parts of the same plant.

Author: Gordana Gorinšek, MSc in Phytomedicine, Expert Cosmetic Safety Assessor, Expert Regulatory Affairs Consultant

Read More